365 related articles for article (PubMed ID: 33016221)
21. Gut-Derived Protein-Bound Uremic Toxins.
Graboski AL; Redinbo MR
Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32932981
[TBL] [Abstract][Full Text] [Related]
22. Diet, gut microbiome and indoxyl sulphate in chronic kidney disease patients.
Yang CY; Tarng DC
Nephrology (Carlton); 2018 Oct; 23 Suppl 4():16-20. PubMed ID: 30298666
[TBL] [Abstract][Full Text] [Related]
23. The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Bennis Y; Cluet Y; Titeca-Beauport D; El Esper N; Ureña P; Bodeau S; Combe C; Dussol B; Fouque D; Choukroun G; Liabeuf S
Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31109001
[TBL] [Abstract][Full Text] [Related]
24. Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease.
Li DY; Tang WHW
Semin Nephrol; 2018 Mar; 38(2):193-205. PubMed ID: 29602401
[TBL] [Abstract][Full Text] [Related]
25. Does Low-Protein Diet Influence the Uremic Toxin Serum Levels From the Gut Microbiota in Nondialysis Chronic Kidney Disease Patients?
Black AP; Anjos JS; Cardozo L; Carmo FL; Dolenga CJ; Nakao LS; de Carvalho Ferreira D; Rosado A; Carraro Eduardo JC; Mafra D
J Ren Nutr; 2018 May; 28(3):208-214. PubMed ID: 29439931
[TBL] [Abstract][Full Text] [Related]
26. Progression of glomerular sclerosis in experimental uremic rats by administration of indole, a precursor of indoxyl sulfate.
Niwa T; Ise M; Miyazaki T
Am J Nephrol; 1994; 14(3):207-12. PubMed ID: 7977482
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach.
Mishima E; Fukuda S; Mukawa C; Yuri A; Kanemitsu Y; Matsumoto Y; Akiyama Y; Fukuda NN; Tsukamoto H; Asaji K; Shima H; Kikuchi K; Suzuki C; Suzuki T; Tomioka Y; Soga T; Ito S; Abe T
Kidney Int; 2017 Sep; 92(3):634-645. PubMed ID: 28396122
[TBL] [Abstract][Full Text] [Related]
28. Intestinal Chelators, Sorbants, and Gut-Derived Uremic Toxins.
Laville SM; Massy ZA; Kamel S; Chillon JM; Choukroun G; Liabeuf S
Toxins (Basel); 2021 Jan; 13(2):. PubMed ID: 33530404
[TBL] [Abstract][Full Text] [Related]
29. Homeostasis in the Gut Microbiota in Chronic Kidney Disease.
Bhargava S; Merckelbach E; Noels H; Vohra A; Jankowski J
Toxins (Basel); 2022 Sep; 14(10):. PubMed ID: 36287917
[TBL] [Abstract][Full Text] [Related]
30. Uremic Toxin-Producing
Shivani S; Kao CY; Chattopadhyay A; Chen JW; Lai LC; Lin WH; Lu TP; Huang IH; Tsai MH; Teng CH; Wu JJ; Hsieh YH; Wang MC; Chuang EY
Front Cell Infect Microbiol; 2022; 12():726256. PubMed ID: 35558102
[TBL] [Abstract][Full Text] [Related]
31. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.
Liu WC; Tomino Y; Lu KC
Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30208594
[TBL] [Abstract][Full Text] [Related]
32. Effects of lactulose on renal function and gut microbiota in adenine-induced chronic kidney disease rats.
Sueyoshi M; Fukunaga M; Mei M; Nakajima A; Tanaka G; Murase T; Narita Y; Hirata S; Kadowaki D
Clin Exp Nephrol; 2019 Jul; 23(7):908-919. PubMed ID: 30895529
[TBL] [Abstract][Full Text] [Related]
33. Nutrients Turned into Toxins: Microbiota Modulation of Nutrient Properties in Chronic Kidney Disease.
Fernandez-Prado R; Esteras R; Perez-Gomez MV; Gracia-Iguacel C; Gonzalez-Parra E; Sanz AB; Ortiz A; Sanchez-Niño MD
Nutrients; 2017 May; 9(5):. PubMed ID: 28498348
[TBL] [Abstract][Full Text] [Related]
34. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.
Kamiński TW; Pawlak K; Karbowska M; Myśliwiec M; Pawlak D
BMC Nephrol; 2017 Jan; 18(1):35. PubMed ID: 28122514
[TBL] [Abstract][Full Text] [Related]
35. Microbial Modulation of a Uremic Toxin.
Skye SM; Hazen SL
Cell Host Microbe; 2016 Dec; 20(6):691-692. PubMed ID: 27978427
[TBL] [Abstract][Full Text] [Related]
36. Effect of prebiotic (fructooligosaccharide) on uremic toxins of chronic kidney disease patients: a randomized controlled trial.
Ramos CI; Armani RG; Canziani MEF; Dalboni MA; Dolenga CJR; Nakao LS; Campbell KL; Cuppari L
Nephrol Dial Transplant; 2019 Nov; 34(11):1876-1884. PubMed ID: 29939302
[TBL] [Abstract][Full Text] [Related]
37. Anthraquinone-containing compound in rhubarb prevents indole production via functional changes in gut microbiota.
Takayama K; Maehara S; Tabuchi N; Okamura N
J Nat Med; 2021 Jan; 75(1):116-128. PubMed ID: 33078328
[TBL] [Abstract][Full Text] [Related]
38. Effect of sucroferric oxyhydroxide on gastrointestinal microbiome and uremic toxins in patients with chronic kidney disease undergoing hemodialysis.
Iguchi A; Yamamoto S; Oda A; Tanaka K; Kazama JJ; Saeki T; Yamazaki H; Ishioka K; Suzutani T; Narita I
Clin Exp Nephrol; 2020 Aug; 24(8):725-733. PubMed ID: 32285213
[TBL] [Abstract][Full Text] [Related]
39. Thrombolome and Its Emerging Role in Chronic Kidney Diseases.
Fryc J; Naumnik B
Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33803899
[TBL] [Abstract][Full Text] [Related]
40. Proton pump inhibitor-induced risk of chronic kidney disease is associated with increase of indoxyl sulfate synthesis via inhibition of CYP2E1 protein degradation.
Lu S; Zhao J; Chen X; Xu S; Yang X; Zhang Y; Ma Z; Jiang H; Zhou H
Chem Biol Interact; 2022 Dec; 368():110219. PubMed ID: 36243147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
